Benralizumab for adolescent patients with severe, eosinophilic asthma: Safety and efficacy after 3 years of treatment

BORA study investigators

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Benralizumab for adolescent patients with severe, eosinophilic asthma: Safety and efficacy after 3 years of treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences